Cargando…

Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders

Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of g...

Descripción completa

Detalles Bibliográficos
Autores principales: Abi Habib, Walid, Brioude, Frédéric, Azzi, Salah, Rossignol, Sylvie, Linglart, Agnès, Sobrier, Marie-Laure, Giabicani, Éloïse, Steunou, Virginie, Harbison, Madeleine D., Le Bouc, Yves, Netchine, Irène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382400/
https://www.ncbi.nlm.nih.gov/pubmed/30801013
http://dx.doi.org/10.1126/sciadv.aau9425
_version_ 1783396663907319808
author Abi Habib, Walid
Brioude, Frédéric
Azzi, Salah
Rossignol, Sylvie
Linglart, Agnès
Sobrier, Marie-Laure
Giabicani, Éloïse
Steunou, Virginie
Harbison, Madeleine D.
Le Bouc, Yves
Netchine, Irène
author_facet Abi Habib, Walid
Brioude, Frédéric
Azzi, Salah
Rossignol, Sylvie
Linglart, Agnès
Sobrier, Marie-Laure
Giabicani, Éloïse
Steunou, Virginie
Harbison, Madeleine D.
Le Bouc, Yves
Netchine, Irène
author_sort Abi Habib, Walid
collection PubMed
description Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 down-regulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS.
format Online
Article
Text
id pubmed-6382400
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-63824002019-02-23 Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders Abi Habib, Walid Brioude, Frédéric Azzi, Salah Rossignol, Sylvie Linglart, Agnès Sobrier, Marie-Laure Giabicani, Éloïse Steunou, Virginie Harbison, Madeleine D. Le Bouc, Yves Netchine, Irène Sci Adv Research Articles Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 down-regulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS. American Association for the Advancement of Science 2019-02-20 /pmc/articles/PMC6382400/ /pubmed/30801013 http://dx.doi.org/10.1126/sciadv.aau9425 Text en Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Abi Habib, Walid
Brioude, Frédéric
Azzi, Salah
Rossignol, Sylvie
Linglart, Agnès
Sobrier, Marie-Laure
Giabicani, Éloïse
Steunou, Virginie
Harbison, Madeleine D.
Le Bouc, Yves
Netchine, Irène
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
title Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
title_full Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
title_fullStr Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
title_full_unstemmed Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
title_short Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders
title_sort transcriptional profiling at the dlk1/meg3 domain explains clinical overlap between imprinting disorders
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382400/
https://www.ncbi.nlm.nih.gov/pubmed/30801013
http://dx.doi.org/10.1126/sciadv.aau9425
work_keys_str_mv AT abihabibwalid transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT brioudefrederic transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT azzisalah transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT rossignolsylvie transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT linglartagnes transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT sobriermarielaure transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT giabicanieloise transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT steunouvirginie transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT harbisonmadeleined transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT leboucyves transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders
AT netchineirene transcriptionalprofilingatthedlk1meg3domainexplainsclinicaloverlapbetweenimprintingdisorders